Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Regencell Bioscience Holdings Limited - Ordinary Shares
(NQ:
RGC
)
28.95
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Regencell Bioscience Holdings Limited - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Today 9:00 EDT
From
Law Offices of Howard G. Smith
Via
Business Wire
Kaplan Fox Alerts Regencell Bioscience Holdings Limited (RGC) Investors of June 23, 2026 Lead Plaintiff Deadline in Securities Class Action Case
April 29, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Law Enforcement
Lawsuit
Kaplan Fox Alerts Regencell Bioscience Holdings Limited (RGC) Investors of June 23, 2026 Lead Plaintiff Deadline in Securities Class Action Case
April 29, 2026
NEW YORK, NY - April 29, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Regencell Bioscience Holdings Limited (“Regencell” or the...
Via
TheNewswire.com
Topics
Law Enforcement
Lawsuit
RGC Stock Gains 20% Pre-Market — Retail Says Shorts Are In ‘Huge Trouble’
↗
January 08, 2026
Via
Stocktwits
Securities Fraud Investigation Into Regencell Bioscience Holdings Limited (RGC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
April 29, 2026
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
April 28, 2026
From
Pomerantz LLP
Via
GlobeNewswire
RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit with the Schall Law Firm
April 28, 2026
From
Schall Law
Via
GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – RGC
April 27, 2026
From
The Rosen Law Firm PA
Via
GlobeNewswire
REGENCELL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Regencell Bioscience Holdings Limited and Encourages Investors to Contact the Firm
April 27, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
April 27, 2026
From
The Rosen Law Firm, P.A.
Via
Business Wire
Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action
April 24, 2026
From
Robbins LLP
Via
Business Wire
Keep an eye on the top gainers and losers in Wednesday's session.
↗
April 01, 2026
Via
Chartmill
Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now
↗
March 06, 2026
Regencell Bioscience doesn't have a product yet, and there's no indication that one is on the way.
Via
The Motley Fool
Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag
↗
March 05, 2026
Regencell Bioscience is working on TCM opportunities, but what exactly is TCM?
Via
The Motley Fool
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
March 03, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need
↗
March 01, 2026
Don't follow general market sentiment when it comes to these two stocks.
Via
The Motley Fool
Top movers in Thursday's session
↗
January 22, 2026
Via
Chartmill
Thursday's session: top gainers and losers
↗
January 22, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Tuesday's session.
↗
January 13, 2026
Via
Chartmill
These stocks are gapping in today's session
↗
January 13, 2026
Via
Chartmill
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
January 08, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
These stocks are gapping in today's session
↗
January 08, 2026
Via
Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session.
↗
January 08, 2026
Via
Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
January 07, 2026
Via
Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session.
↗
January 07, 2026
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
January 05, 2026
Via
Chartmill
Keep an eye on the top gainers and losers in Monday's session.
↗
January 05, 2026
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
January 05, 2026
Via
Chartmill
Regencell Bioscience (RGC) Stumbles into 2026: 8% Year-End Slide Sparks Technical Caution
January 01, 2026
As the final bells rang on the 2025 trading year, investors in Regencell Bioscience (NASDAQ: RGC) were met with a sobering reality check. The Hong Kong-based biotech firm, which has enjoyed a meteoric...
Via
MarketMinute
Bragar Eagel & Squire, P.C. Continues Investigations into Regencell and Camping World on Behalf of Stockholders and Encourages Investors to Contact the Firm
December 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.